Inhibition of MspI cleavage activity by hydroxymethylation of the CpG site: a concern for DNA modification studies

Kenji Ichiyanagi1

  • 1Division of Epigenomics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan. ichiyanagi@bioreg.kyushu-u.ac.jp

Epigenetics
|March 8, 2012
PubMed

Insights

The restriction enzyme MspI is inhibited by 5-hydroxymethyl-cytosine (5-hmC), affecting DNA modification studies. Alternative enzymes like TaqI and HaeIII show resistance to hydroxymethylation, suggesting careful interpretation of MspI-based analyses.

Area of Science:

  • Epigenetics
  • Molecular Biology
  • Genomics

Background:

  • Cytosine methylation in mammalian DNA, primarily at CpG sites, is a key epigenetic regulator.
  • 5-methyl-cytosine (5-mC) can be converted to 5-hydroxymethyl-cytosine (5-hmC) by ten-eleven translocation (TET) enzymes.
  • Restriction enzymes are commonly used to study DNA modifications.

Purpose of the Study:

  • To investigate the kinetic effects of 5-hydroxymethyl-cytosine (5-hmC) on the activity of the restriction enzyme MspI.
  • To compare the sensitivity of MspI, TaqI, and HaeIII to hydroxymethylation in their recognition sequences.

Main Methods:

  • Kinetic analysis of MspI activity in the presence of varying degrees of cytosine hydroxymethylation.
  • Comparative analysis of TaqI and HaeIII resistance to hydroxymethylation.

Main Results:

  • MspI activity is significantly reduced by symmetrical hydroxymethylation of its recognition site.
  • MspI activity is partially inhibited by hemi-hydroxymethylation.
  • TaqI and HaeIII exhibit relative resistance to hydroxymethylation compared to MspI.

Conclusions:

  • DNA modification studies employing MspI, including reduced representation bisulfite sequencing and 5-hmC analysis, require careful interpretation due to enzyme inhibition by 5-hmC.
  • The findings highlight the importance of considering the impact of DNA modifications on restriction enzyme activity for accurate epigenetic research.

Related Concept Videos

Restriction Enzymes01:11

Restriction Enzymes

Restriction enzymes are bacterial enzymes used to cut DNA in a sequence-specific manner. To cleave DNA, they bind to specific palindromic sequences called restriction sites. Such palindromic DNA sequences or inverted repeats are commonly found in regions of functional significance, such as the origin of replication, gene operator sites, and regions containing transcription termination signals.
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...